Evidence map›Paper›PMID 36105060›Full record

ArticleAmerican journal of translational research2022

Comparison of

Jiahui Jin, Jingjing He, Xinyu Yan, Yaru Zhao, Haojie Zhang, Kai Zhuang, Yating Wen, Junzhen Gao

Open access · greenAbstract read
PubMed Full text at PMC
In one paragraph

Article in American journal of translational research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Jiahui JinDepartment of Oncology, Affiliated Qingdao Central Hospital, Qingdao University Qingdao 266042, Shandong Province, China.
Jingjing HeGeriatric Department, The Affiliated People's Hospital of Inner Mongolia Medical University Hohhot 010010, Inner Mongolia, China.
Xinyu YanRespiratory and Critical Care Medicine, The Affiliated Hospital of Inner Mongolia Medical University Hohhot 010050, Inner Mongolia, China.
Yaru ZhaoRespiratory and Critical Care Medicine, The Affiliated Hospital of Inner Mongolia Medical University Hohhot 010050, Inner Mongolia, China.
Haojie ZhangRespiratory and Critical Care Medicine, The Affiliated Hospital of Inner Mongolia Medical University Hohhot 010050, Inner Mongolia, China.
Kai ZhuangRespiratory and Critical Care Medicine, The Affiliated Hospital of Inner Mongolia Medical University Hohhot 010050, Inner Mongolia, China.
Yating WenRespiratory and Critical Care Medicine, The Affiliated Hospital of Inner Mongolia Medical University Hohhot 010050, Inner Mongolia, China.
Junzhen GaoRespiratory and Critical Care Medicine, The Affiliated Hospital of Inner Mongolia Medical University Hohhot 010050, Inner Mongolia, China.
Second Affiliated Hospital of Inner Mongolia Medical University · CNInner Mongolia Medical University · CNQingdao University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundScreening for epidermal growth factor receptor (

methodsOne hundred and seventy-nine NSCLC patients with both tumor tissue samples and paired plasma samples were recruited.

resultsOf the 179 patients,

conclusionIn plasma samples, Anlongen LAN-ARMS

Indexed as

epidermal growth factor receptor (EGFR)Locked nucleic acid-amplification refractory mutation system (LNA-ARMS)lung cancer

Identifiers

PMID36105060
PMCPMC9452314
OpenAlexW4295899639

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.